Cara Therapeutics
(CARA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CARA | AZN | AMGN | GILD | BMY |
| Company | Cara Therapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 16.17 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 16.56 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 15.84 | 190.60 | 366.88 | 149.54 | 59.95 |
| Latest | 15.96 | 193.76 | 367.97 | 149.88 | 60.57 |
| Change | -0.69 | +5.75 | -7.85 | -1.80 | -0.20 |
| % Change | -4.14% | +3.06% | -2.09% | -1.19% | -0.33% |
| Volume | 79,033 | 1,178,508 | 531,658 | 1,536,380 | 3,063,463 |
| 20-Day Average Volume | 30,465 | 4,617,544 | 3,019,921 | 7,901,385 | 13,147,054 |
| Previous Close | 16.65 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.16 | 187.36 | 347.67 | 137.41 | 56.46 |
| 20-Day Raw Stochastic | 65.04% | 86.06% | 73.57% | 90.47% | 78.31% |
| 20-Day Relative Strength | 54.57 | 57.48 | 61.61 | 72.06 | 65.88 |
| Weighted Alpha | -27.45 | +37.13 | +33.05 | +52.65 | +22.83 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.69% since 04/08/25 | +4.89% since 02/03/26 | +8.64% since 02/03/26 | +4.69% since 02/03/26 | +7.53% since 02/03/26 |
| Low | 4.71 on 04/09/25 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 5.75 on 04/14/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +3.70% since 03/14/25 | +2.13% since 01/09/26 | +12.80% since 01/09/26 | +23.86% since 01/09/26 | +7.78% since 01/09/26 |
| Low | 4.52 on 04/07/25 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 5.75 on 04/14/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +19.28% since 01/15/25 | +10.50% since 11/10/25 | +13.65% since 11/10/25 | +26.95% since 11/10/25 | +27.39% since 11/10/25 |
| Low | 4.30 on 03/05/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 6.00 on 01/27/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +73.86% since 10/15/24 | +31.43% since 08/08/25 | +27.62% since 08/08/25 | +25.61% since 08/08/25 | +31.02% since 08/08/25 |
| Low | 2.71 on 12/18/24 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 6.36 on 12/31/24 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,332 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 4,574 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 7,140,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -70,870,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,460,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,680,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.41 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.80 on 11/14/24 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/25 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.12 | 17.59 | 18.62 | 10.08 |